Carmen L. De Cunto

Buenos Aires, C, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Identifying global trends from case reports of fibrodysplasia ossificans progressiva: a scoping review.

Identifying global trends from case reports of fibrodysplasia ossificans progressiva: a scoping review.

Journal: Therapeutic advances in musculoskeletal disease

Published: September 05, 2025

Medical guidelines for fibrodysplasia ossificans progressiva.

Medical guidelines for fibrodysplasia ossificans progressiva.

Journal: JBMR plus

Published: August 04, 2025

Palovarotene in fibrodysplasia ossificans progressiva: review and perspective.

Palovarotene in fibrodysplasia ossificans progressiva: review and perspective.

Journal: Expert opinion on pharmacotherapy

Published: January 21, 2025

Transition From Pediatric to Adult Rheumatology Care: An Exploratory Study From Latin America.

Transition From Pediatric to Adult Rheumatology Care: An Exploratory Study From Latin America.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: January 11, 2024

Long-term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva.

Long-term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva.

Journal: Rheumatology (Oxford, England)

Published: December 07, 2023

Transition in chronic gastrointestinal diseases. From pediatric to adult care

Transition in chronic gastrointestinal diseases. From pediatric to adult care

Journal: Archivos argentinos de pediatria

Published: May 16, 2023

Most Fractures Treated Nonoperatively in Individuals With Fibrodysplasia Ossificans Progressiva Heal With a Paucity of Flareups, Heterotopic Ossification, and Loss of Mobility.

Most Fractures Treated Nonoperatively in Individuals With Fibrodysplasia Ossificans Progressiva Heal With a Paucity of Flareups, Heterotopic Ossification, and Loss of Mobility.

Journal: Clinical orthopaedics and related research

Published: December 12, 2022

Clinical characteristics and course of patients with Kawasaki disease at a general hospital.

Clinical characteristics and course of patients with Kawasaki disease at a general hospital.

Journal: Archivos argentinos de pediatria

Published: October 13, 2022

Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP).

Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP).

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: August 10, 2022

Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva.

Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva.

Journal: BMC medical research methodology

Published: July 22, 2022

The natural history of fibrodysplasia ossificans progressiva: A prospective, global 36-month study.

The natural history of fibrodysplasia ossificans progressiva: A prospective, global 36-month study.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: June 17, 2022

Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles.

Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles.

Journal: Human gene therapy

Published: May 03, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026